Dec 18, 2024, 08:38 AM by

Oxford Nanopore Technologies will participate in a groundbreaking study will analyse the entire genetic code of up to 17,000 people with Myalgic Encephalomyelitis (ME) in a bid to uncover the genetic causes of the illness.

Dec 18, 2024, 01:00 AM by User Not Found

Bio-IT World | In a Perspectives paper published last week in Cell, researchers from Stanford University, Genentech, and the Chan-Zuckerberg Initiative issued a call for AI to build a virtual cell. Technology is ripe for a biologically-valuable virtual cell, they say, outlining their views of the priorities and opportunities.

Dec 17, 2024, 09:06 AM by User Not Found

Bio-IT World | It has been a momentous year for artificial intelligence and machine learning. AI models can simulate clinical trials, diagnose diseases early, and detect biomarkers, and there is still no shortage of innovative ideas. However, there are some concerns surrounding AI/ML that have also been at the forefront of the industry. The latest episode of Trends from the Trenches covers one of these concerns.

Dec 16, 2024, 08:12 AM by

Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) – the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners.

Dec 16, 2024, 08:12 AM by

BC Platforms, a global leader in real-world data, healthcare data management, and analytics, has announced an extended, joint partnership with the University of Nottingham (UoN) and Nottingham University Hospitals NHS Trust (NUH) to provide data-sharing platforms and tools facilitating data sharing, security, and advanced analyses including Trusted Research Environments (TREs*). The outputs of analysing such data, from both clinical and basic research, have the potential to transform our understanding of important healthcare trends, as well as studying devastating diseases such as cancer and diabetes up to the population level. They could also potentially help unlock innovative new solutions and therapies for patients everywhere.

Dec 13, 2024, 07:55 AM by

Coronado Research announced today that Dr Jennifer Bradford has been appointed as VP, Head of Data Science.

Dec 13, 2024, 07:55 AM by

VieCure announced Commonwealth Cancer Center will deploy its Halo Intelligence platform - the first AI-enabled community oncology care solution. Clinicians will use the platform to manage precision oncology data and help determine the optimal personalized treatment path for patients across rural Kentucky.

Dec 13, 2024, 01:00 AM by User Not Found

Bio-IT World | Japan has long taken a leadership role in the pursuit of boron neutron capture therapy (BNCT) as a treatment for cancer. The approach involves injecting patients with a boron-containing compound that accumulates in tumor cells and acts as an exclusive target for neutrons to kill and was the research focus of a pair of Harvard scientists throughout the 1950s.

Dec 12, 2024, 08:05 AM by

Dec 11, 2024, 08:05 AM by

Indica Labs today announces that the Institute of Tissue Medicine and Pathology at the University of Bern has selected HALO AP® for the Institute’s first-in-country digital pathology deployment in the cloud powered by Amazon Web Services, Inc.

Dec 11, 2024, 08:05 AM by

ZeOmega®, the leading population health management organization, today announced that it was recognized as a Major Player in the IDC MarketScape: U.S. Health Plan Prior Authorization Solutions 2024 Vendor Assessment (doc #US51810824, November 2024) report. ZeOmega believes this distinction reflects its innovative use of AI and other technologies to optimize prior authorization processes and meet interoperability standards, empowering health plans to improve provider satisfaction and member outcomes with faster, more efficient approvals.

Dec 11, 2024, 08:05 AM by

Dec 11, 2024, 01:00 AM by User Not Found

Bio-IT World | An intriguing new study suggests that the people we interact with socially influence the bacteria populating our gut. The implication is that some diseases considered nontransmissible may have a component that makes them contagious.

Dec 10, 2024, 05:40 AM by

The first AI-driven assistant of its kind in the preclinical oncology space, CertisOI Assistant enables users to query vast datasets, perform complex computational analyses, and visualize drug efficacy predictions—all through a seamless, natural language interface. With this solution, Certis is redefining how researchers interact with oncology data, promising to accelerate the development of new cancer therapies and the realization of personalized medicine. Highly specialized for oncology research, CertisOI Assistant’s conversational interface and integration with CertisAI, Certis’ proprietary AI/ML platform allow cancer scientists to easily query both public and proprietary tumor model datasets; perform complex ad hoc analyses; convert results into downloadable tables, charts, and graphs for actionable insights, and leverage AI-generated drug response predictions to inform critical research decisions.

Dec 10, 2024, 05:40 AM by

DNAnexus and Panomics to Deliver Multi-omics Data Solutions for Biopharma

Dec 10, 2024, 05:40 AM by

Dec 10, 2024, 05:40 AM by

Sapio Sciences, the science-aware™ lab informatics platform, today announced that evitria, a leader in antibody expression services, has selected Sapio’s Electronic Lab Notebook (ELN) and Sapio Report Builder to enhance its sample tracking, data capture, and reporting capabilities.

Dec 10, 2024, 05:40 AM by

Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.

Dec 10, 2024, 01:00 AM by User Not Found

Bio-IT World | A project to study the genomes of living organisms in the Arctic region, known as “A Thousand Arctic Genomes,” has been launched in Russia. As part of the project, scientists will create genetic data banks and perform whole-genome sequencing of Arctic inhabitants in order to assess biodiversity and use the data obtained to preserve it.

Dec 9, 2024, 08:07 AM by

Oxford Nanopore Technologies announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.